Lv2
120 积分 2021-12-23 加入
The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases
14天前
已完结
POS0697 EGL-003: AN OPTIMIZED IL-2 MUTEIN DESIGNED TO EXPAND REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
15天前
已关闭
Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel
15天前
已完结
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy
18天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
21天前
已完结
Blood-brain barrier permeability in the ischemic stroke: An update
23天前
已完结
Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier
23天前
已关闭
Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry
1个月前
已关闭
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
1个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
1个月前
已完结
皖公网安备34019202002308
